Crescent Capital BDC (NASDAQ:CCAP) Issues Earnings Results, Misses Estimates By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) issued its earnings results on Wednesday. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01), Zacks reports. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. The firm had revenue of $46.40 million during the quarter, compared to analyst estimates of $47.27 million.

Crescent Capital BDC Stock Down 4.8 %

Shares of NASDAQ CCAP opened at $19.05 on Thursday. Crescent Capital BDC has a 1 year low of $16.38 and a 1 year high of $20.19. The firm has a market cap of $705.99 million, a price-to-earnings ratio of 7.45 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. The stock’s 50-day simple moving average is $19.48 and its 200-day simple moving average is $18.86.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.82%. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date was Tuesday, December 31st. Crescent Capital BDC’s payout ratio is presently 65.88%.

Analyst Ratings Changes

CCAP has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their target price on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Wednesday, January 29th. Keefe, Bruyette & Woods lifted their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $19.33.

Read Our Latest Research Report on CCAP

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.